Position in PCVX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$393,423
+$8,910 QoQ
Shares Held
6,768
+2.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#205
of 329 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Values First Advisors, Inc. holds $10,629,094 across 12 Biotechnology names. PCVX ranks #9 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
40,301 | $2,847,264 | |
| 2 | RPRX |
Royalty Pharma plc
|
21,005 | $1,177,750 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
9,479 | $1,109,706 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
19,463 | $1,070,465 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,178 | $956,673 | |
| 6 | ARGX |
Argenx SE
|
999 | $926,842 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
3,320 | $812,636 | |
| 8 | EXEL |
Exelixis, Inc.
|
14,397 | $783,340 |
All Filings in PCVX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,423 | 6,768 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $384,513 | 6,617 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $215,935 | 4,680 | Shares | Sole | 2026-01-30 | |
| 2024-09-30 | $174,490 | 1,527 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||